Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche/GSK Once-Quarterly Boniva Injection Approved

This article was originally published in The Pink Sheet Daily

Executive Summary

Injectable ibandronate could improve patient compliance with osteoporosis therapy because it is administered by a healthcare professional, firms say.
Advertisement

Related Content

Novartis On The Move: Firm Files Tasigna, Aclasta Ahead Of Schedule
Novartis On The Move: Firm Files Tasigna, Aclasta Ahead Of Schedule
Roche Plans Boniva Ad Changes To Energize “Static” Script Growth
Roche Plans Boniva Ad Changes To Energize “Static” Script Growth
Roche/GSK Boniva Once-Monthly To Be Launched In April
Roche/GSK Boniva Once-Monthly To Be Launched In April

Topics

Advertisement
UsernamePublicRestriction

Register

PS063153

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel